1.Reference value of biochemical indicator and imaging medicine in jaundice-relieving effect of Yinchenhao Decoction
China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(12):-
We can discriminate the cause and classi cation of jaundice by biochemical indicator and imaging medicine.It suggests that Yinchenhao decoction can get a remarkable curative effect on the recessive jaundice and hepatocellular jaundice.But for severe obstructive jaundice,Yinchenhao decoction has no good jaundice-relieving effect.
2.STUDIED ON THE ENRICNMENT OF EPA AND DHA FROM FISH OIL BY LOWER TEMPERATURE CRYSTALLIZATION
He LI ; Peiwen LI ; Yiping YANG
Chinese Journal of Marine Drugs 1994;0(04):-
The Contents of EPA and DHA were enriched from fish oil by lower temperature crystallization. After first separation,the concentration of EPA and DHA went up to 50%-58% from 7%-15%,and to 73%-79%after sencond separation. The selection of solvents and conditions of crystallization were discussed.
3.Clinical Study on Xiaoshui Formula Ⅱ for Treatment of 31 Cases of Malignant Ascites
Yumei HE ; Sufen XUE ; Peiwen LI
Journal of Traditional Chinese Medicine 1993;0(05):-
Objective:To observe the therapeutic effect of Xiaoshui Formula Ⅱ on malignant ascites.Methods:60 cases of malignant ascites were randomly divided into a treatment group and a control group.The treatment group was treated with external application of Xiaoshui Formula Ⅱ and the control group with intraperitoneal injection of DDP.The therapeutic effect of Xiaoshui Formula Ⅱ was observed.Results:The total effective rate of ascites resolution was 87.1% in the treatment group and 58.6% in the control group.There were significant differences in improvement of clinical symptoms,Karnofsky score and correlative indexes between the two groups.Conclusion:Xiaoshui Formula Ⅱ has better therapeutic effect than intraperitoncal injection of DDP,with no side effect.
4.A review of the therapy of aged lung cancer
Yichen XU ; Shijie ZHU ; Peiwen LI
Cancer Research and Clinic 2009;21(1):1-3
The article briefly reviews the aged lung cancer in epidemiology, physical and pathologic traits, and treatments. It includes the matters needing attention of operation with elder lung cancer patients; matters about the radiotherapy; choice of chemotherapeutics or dosage; situation of targeted drug and treatment of Chinese Medicine. Goals of treatment with elder lung cancer patients are prolonging lifetime, improving quality of life. Patients should be treated individually according to their state of illness and constitutions.
5.Clinical evaluation of the efficacy of external therapies of traditional Chinese medicine in treatment of cancer pain.
Shijie ZHU ; Liqun JIA ; Peiwen LI
Journal of Integrative Medicine 2011;9(1):11-4
There lack scientific methods for evaluating the treatment of cancer pain with external therapies of traditional Chinese medicine (TCM). The level of clinical study in this field needs to be improved. The authors assert that when external therapies of TCM are applied to treat cancer pain, different types of cancer pain should be distinguished and treatment should be applied according to such a differentiation. Under this framework scientific evaluation can be conducted. The authors also assert that the findings of randomized, blinded and controlled trials should be given particular attention, and it is necessary to include titration of morphine into clinical trails of external therapies for the treatment of cancer pain, not only complying with the three-ladder principle for treating cancer pain suggested by the World Health Organization, but also not influencing the effect evaluation of external therapies of TCM on cancer pain. Patient diaries recording pain were revised as observation indexes. The primary indicator of efficacy was the pain intensity score and the secondary indicators were the equivalent of morphine and the remission rate of pain. The time to onset, remission duration and comparison of assessment of pain influence can mirror the characteristics of external therapies of TCM on cancer pain.
6.Pingfei Mixture's two-way adjustment to cell proliferation in mice with tumor
Shijie ZHU ; Peiwen LI ; Liqun JIA
Journal of Integrative Medicine 2003;1(3):202-4
OBJECTIVE: To study the antineoplastic mechanism of Pingfei Mixture. METHODS: Thirty C57BL mice bearing Lewis pulmonary carcinoma were randomly divided into 3 groups: saline control group, Pingfei Mixture group and cisplatin group. Fifteen days later, tumor tissues and spleens were taken out and made into unicellular suspension. Argyrophil staining was taken to carcinoma cells and cultured T cells. KL-2 style cell image analysis system was used to analyze the rate between AgNORs and nuclear region (I.S). RESULTS: There were dense brownish-black granules in tumor cell nuclear of saline control group. The brownish-black granules of Pingfei Mixture group and cisplatin group were less than those of saline control group. The differences of T cell I.S in these three groups were significant. The I.S of Pingfei Mixture was higher than that of the other groups, and the I.S of the cisplatin group was the lowest. CONCLUSION: Pingfei Mixture can inhibit tumor cell proliferation, although the effect is inferior to cisplatin. Pingfei Mixture can also promote T cell proliferation and its effect was superior to cisplatin.
7.Effect of Elemene on Transcription Factor ELK1 and Its Target Gene of Human Cervix Cancer Hela Cell
Xiaojun CHEN ; Ligang GU ; Peiwen LI
Chinese Journal of Information on Traditional Chinese Medicine 2006;0(01):-
Objective To study the effect of elemene on transcription factor ELK1 and its target gene in human cervix cancer Hela cell. Methods The cell proliferation was assessed by MTT assay. The luciferase activity of transcription factor ELK1 was determined by the Dual-Luciferase Reporter Assay System. The protein expression of phosphorated ELK1 and its target gene c-fos were determined by Western Blot. Results Elemene can remarkably inhibited the growth of Hela cell and its IC50 was 80.6 ?g/mL. The luciferase activity of transcription factor ELK1 in Hela cells treated with elemene was inhibited. The protein expression of phosphorated ELK1 and its target gene c-fos in Hela cells treated with elemene were down-regulated. Conclusion Elemene can inhibit human cervix cancer Hela cell proliferation,which may be related with suppression of c-fos gene through inhibiting expression of phosphorated ELK1.
8.?-ray dose rate effect in DNA double-strand break repair deficient murine cells
Liya LI ; Jintian TANG ; Taisei NOMURA ; Heroo NAKAJIMA ; Peiwen LI
Chinese Journal of Radiation Oncology 1993;0(03):-
Objective To analyze the dose rate effect and potentially lethal damage repair in DNA double strand break repair deficient murine cells (SCID) irradiated by ? ray. Methods The wild type(CB.17+/+) and SCID cells were exposed to ? ray at high and low dose rates. The high dose rate exposure was fractionated into two equal doses at 24?h intervals. The survival rates of irradiated cells were calculated by clony forming analysis. Results When ? ray was given to wild type(CB.17+/+) cells in two fractions at 24?h intervals, the survival rate was significantly higher than that when the same total dose was given singly. In contrast, there was no difference in the survival rates between the single and fractionated exposure in SCID cells. SCID cells were more sensitive than CB.17+/+ cells to both low and high dose rates ? ray exposure for cell killing. The survival rate by low dose rate exposure was significantly higher than that by high dose rate exposure, not only in CB.17+/+ cells but also in SCID cells. Conclusions SCID cells are deficient in repairing ? ray induced double strand breaks. There is dose rate effect in both SCID and CB.17+/+ cells.
9.Observation on the Clinical Efficacy of Cancer-linked Hyperhidrosis with Neuropad Diagnostic Patches
Yuren LIN ; Liqun JIA ; Liya LI ; Bo DENG ; Peiwen LI
International Journal of Traditional Chinese Medicine 2009;31(6):497-498
Objective To observe the clinical efficacy of applying Sweat Reduction Formula (SRF) externally in the treatment of cancer-linked hyperhidrosis. Methods 45 tumor patients, who exhibited excessive perspiration, were selected and recruited randomly into an experimental group (Sweat Reduction Formula group) with 24 patients in it and a control group (Placebo group) with 21 patients in it. The experimental group was treated with SRF and the control group was administrated with placebo. Neuropad diagnostic patches were used to observe the period of time that required for any visual changes in color before and after medication. These observations were then matched with the commonly seen signs and symptoms scoring table, to evaluate the changes of symptoms and KPS. Results The color changing time of the experimental group was 14.45±3.91 min. and 19.51±5.30 min. before and after medications respectively. And the changing time in the control group was 13.49±4.96 min. After medication. The results were highly significant with P<0.05. There were also different levels of significant improvements in terms of spontaneous perspiration, night sweating, dry mouth, feverish sensation over hand-foot centers and body, aversion to cold etc after the treatment in the experimental group. Conclusion It would be more objective to evaluate the clinical efficacy of applying SRF on navel to treat cancer-linked hyperhidrosis with neuropad diagnostic patches.
10.Phenotypic diversity of human nature and induced CD4+CD25+FoxP3+CD127-regulatory T cells
Haihao WANG ; Li ZHU ; Peiwen YANG ; Qiannan GUO
Chinese Journal of Tissue Engineering Research 2016;(2):236-241
BACKGROUND:Regulatory T cels (Treg) are classified into two subsets, nature Treg (nTreg) and induced Treg (iTreg). Although there is consensus that CD4+CD25+FoxP3+CD127-is the widely accepted phenotype of Treg, it remains unclear what is the difference in phenotypes including cytokine patterns of nTreg and iTreg. OBJECTIVE:To understand and compare the plasticity of nTreg and iTreg and to search the exact mechanism of cytokine secretion in Tregs. METHODS: We investigated the frequency and cytokine pattern of CD4+CD25+FoxP3+CD127-nTreg in freshly separated peripheral blood mononuclear cels of five healthy individuals using 8-color fluorescence flow cytometry (FACSCanto II). Subsequently, after 9 days of alostimulation in mixed lymphocytes, the frequency and cytokine pattern of CD4+CD25+FoxP3+CD127-iTreg were determined and analyzed. RESULTS AND CONCLUSION:In fresh cels, (1.5±0.70)% of CD4+ T cels were CD4+CD25+FoxP3+CD127- nTregs. Almost al these cels expressed interferon (IFN)-γ-, interleukin (IL)-2- or transforming growth factor-β+, and partial cels expressed IL-10+ or IL-10-. After 9-day alostimulation, the number of CD4+CD25+FoxP3+CD127- iTreg expressing IFN-γ+, IL-2-, IL-2+, IL-10+ or TGF-β+increased strongly. The main subsets of human nTregs were CD4+CD25+FoxP3+CD127-IFN-γ-IL-2-IL-10+TGF-β+and CD4+CD25+FoxP3+CD127-IFN-γ-IL-2-IL-10-TGF-β+ T cels. The proportion of each subset in CD4+ T cels was (1.1±0.59)% and (0.39±0.16)%, respectively. Whereas the main subsets of human iTregs were CD4+CD25+FoxP3+CD127-IFN-γ+IL-2-IL-10+TGF-β+ and CD4+CD25+FoxP3+CD127-IFN-γ+IL-2+IL-10+TGF-β+. Human nTregs were characterized as IFN-γ-IL-2- double negative, producing IL-10 and TGF-β or only TGF-β without IL-10, and not proliferatingin vitro. During the alostimulation in mixed lymphocytes, IFN-γ+ iTregs proliferated remarkably. One-third of IFN-γ+ iTreg expressed IL-2+, and two-thirds of IFN-γ+ iTregs expressed IL-2, both of which produce IL-2 and TGF-β. Our results imply that CD4+CD25+FoxP3+CD127- Treg are potentialy immunosuppressive probably because of their mandatory TGF-β and optional IL-10 production.